Ahlskog JE - Search Results

1

Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.

Hassan A, Heckman MG, Ahlskog JE, Wszolek ZK, Serie DJ, Uitti RJ, van Gerpen JA, Okun MS, Rayaprolu S, Ross OA. Hassan A, et al. Among authors: ahlskog je. Parkinsonism Relat Disord. 2016 Jan;22:102-5. doi: 10.1016/j.parkreldis.2015.11.016. Epub 2015 Nov 25. Parkinsonism Relat Disord. 2016. PMID: 26627941 Free PMC article.

2

Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease.

Britton JW, Uitti RJ, Ahlskog JE, Robinson RG, Kremer B, Hayden MR. Britton JW, et al. Among authors: ahlskog je. Neurology. 1995 Mar;45(3 Pt 1):443-7. doi: 10.1212/wnl.45.3.443. Neurology. 1995. PMID: 7898693 Free article.

3

Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project.

Uitti RJ, Ahlskog JE, Maraganore DM, Muenter MD, Atkinson EJ, Cha RH, O'Brien PC. Uitti RJ, et al. Among authors: ahlskog je. Neurology. 1993 Oct;43(10):1918-26. doi: 10.1212/wnl.43.10.1918. Neurology. 1993. PMID: 8413948

4

No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.

Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Petersen RC, Kokmen E. Ahlskog JE, et al. Mov Disord. 1995 Sep;10(5):566-73. doi: 10.1002/mds.870100507. Mov Disord. 1995. PMID: 8552107

5

Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease.

Ahlskog JE, Uitti RJ, Low PA, Tyce GM, O'Brien JF, Nickander KK. Ahlskog JE, et al. Neurology. 1996 Mar;46(3):796-801. doi: 10.1212/wnl.46.3.796. Neurology. 1996. PMID: 8618686

6

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

Uitti RJ, Rajput AH, Ahlskog JE, Offord KP, Schroeder DR, Ho MM, Prasad M, Rajput A, Basran P. Uitti RJ, et al. Among authors: ahlskog je. Neurology. 1996 Jun;46(6):1551-6. doi: 10.1212/wnl.46.6.1551. Neurology. 1996. PMID: 8649547

7

Does levodopa therapy delay death in Parkinson's disease?

Uitti RJ, Ahlskog JE, Maraganore DM. Uitti RJ, et al. Among authors: ahlskog je. Mov Disord. 1996 May;11(3):343-4. Mov Disord. 1996. PMID: 8723162 No abstract available.

8

Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases.

Ahlskog JE, Uitti RJ, Tyce GM, O'Brien JF, Petersen RC, Kokmen E. Ahlskog JE, et al. J Neurol Sci. 1996 Mar;136(1-2):162-8. doi: 10.1016/0022-510x(95)00318-v. J Neurol Sci. 1996. PMID: 8815165

9

Diagnostic steps for suspected Parkinson's disease.

Ahlskog JE. Ahlskog JE. Contemp Intern Med. 1995 Jan;7(1):22-30. Contemp Intern Med. 1995. PMID: 10150330

10

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.

Ahlskog JE, Uitti RJ, O'Connor MK, Maraganore DM, Matsumoto JY, Stark KF, Turk MF, Burnett OL. Ahlskog JE, et al. Mov Disord. 1999 Nov;14(6):940-6. doi: 10.1002/1531-8257(199911)14:6<940::aid-mds1005>3.0.co;2-y. Mov Disord. 1999. PMID: 10584667 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

292 results

Search Page